People: Pfizer Inc (PFE)

PFE on New York Consolidated

30.06USD
31 Oct 2014
Price Change (% chg)

$0.22 (+0.72%)
Prev Close
$29.84
Open
$30.01
Day's High
$30.20
Day's Low
$29.99
Volume
7,858,585
Avg. Vol
24,694,983
52-wk High
$32.96
52-wk Low
$27.51

Search Stocks

Dolsten, Mikael 

Brief Biography

Dr. Mikael Dolsten, M.D., Ph.D., is President - Worldwide Research and Development of Pfizer Inc., since December 2010. He was Senior Vice President; President of Worldwide Research and Development from May 2010 until December 2010. Senior Vice President; President of Pfizer BioTherapeutics Research & Development Group from October 2009 until May 2010. He was Senior Vice President of Wyeth and President, Wyeth Research from June 2008 until October 2009. He was a Private Equity Partner at Orbimed Advisors, LLC from January 2008 until June 2008.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
2,488,750 -- 2,129,110 6,453,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ian Read

18,947,700

Frank D'Amelio

7,124,330

Albert Bourla

--

Mikael Dolsten

6,453,400

Geno Germano

5,254,050

John Young

5,201,060
As Of 30 Dec 2013
Search Stocks